Publications Database

Accordino R. E. et al. (2016)

Psychopharmacological interventions in autism spectrum disorder.

Expert Opinion on Pharmacotherapy

May, 17(7), pp. 937-952.

Read Abstract (New Window)

Althaus M. et al. (2015)

Oxytocin enhances orienting to social information in a selective group of high-functioning male adults with autism spectrum disorder.

Neuropsychologia

December, 79 pp. 53-69.

Read Abstract (New Window)

Alvares G. A. , Quintana D. S. , Whitehouse A. J. (2017)

Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder.

Autism Research

10 pp. 25–41.

Read Abstract (New Window) Read Full (New Window)

Anagnostou E. et al. (2014)

Intranasal oxytocin in the treatment of autism spectrum disorders: A review of literature and early safety and efficacy data in youth.

Brain Research

pii: S0006-8993(14)00134-6

Read Abstract (New Window)

Anagnostou E. et al. (2012)

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.

Molecular Autism

3(16),

Read Abstract (New Window) Read Full (New Window)

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Andari E. et al. (2010)

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders.

Proceedings of the National Academy of Science U S A

107(9), pp. 4389-4394

Read Abstract (New Window)

Aoki Y. et al. (2014)

Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.

Brain

November, 137(11), pp. 3073-3086.

Read Abstract (New Window)

Appleton R. E. et al. (2011)

Mends: the use of melatonin in children with neuro-developmental disorders and impaired sleep - a randomised, double-blind, placebo-controlled, parallel trial.

Archives of Disease in Childhood

96 A1

Read Abstract (New Window)

Auyeung B. et al. (2015)

Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism.

Translational Psychiatry

e. 507

Read Abstract (New Window) Read Full (New Window)

Ayyash H. F. et al. (2015)

Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study.

Expert Review of Neurotherapeutics

June, 15(6), pp. 711-717.

Read Abstract (New Window)

Bartz J. A. , Hollander E. (2008)

Oxytocin and experimental therapeutics in autism spectrum disorders.

Progress in Brain Research

170 pp. 451-462

Read Abstract (New Window)

Cai Q. , Feng L. , Yap K. Z.

Systematic review and meta-analysis of reported adverse events of long-term intranasal oxytocin treatment for autism spectrum disorder.

Psychiatry and Clinical Neurosciences

Read Abstract (New Window)

Campbell M. et al. (1978)

A controlled crossover study of triiodothyronine in autistic children.

Journal of Autism and Child Schizophrenia

8(4), pp. 371-381

Read Abstract (New Window)

Campbell M. et al. (1972)

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children.

Journal of Autism and Developmental Disorders

2(4),

Read Abstract (New Window)

Carey T. et al. (2002)

Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism.

Journal of Autism and Developmental Disorders

32(3), pp. 161-167

Read Abstract (New Window)

Chez M. G. et al. (2000)

Secretin and autism: a two-part clinical investigation.

Journal of Autism and Developmental Disorders

30(2), pp. 87-94

Read Abstract (New Window)

Coniglio S. J. et al. (2001)

A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.

Journal of Pediatrics

138(5), pp. 649–655.

Coplan J. et al. (2003)

Children with autistic spectrum disorders. II: Parents are unable to distinguish secretin from placebo under double-blind conditions.

Archives of Disease in Childhood

88(9),

Read Full (New Window)

Corbett B. A. , Khan K. , Czapansky-Beilman D. (2001)

A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.

Clinical Pediatrics

40(6),

Read Abstract (New Window)